This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Mar;18(1):1-19.

doi: 10.1016/0305-7372(91)90002-h.

Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reduction

J Koning¹, P Palmer, C R Franks, D E Mulder, J L Speyer, M D Green, K Hellmann

Affiliations

PMID: 1933909
DOI: 10.1016/0305-7372(91)90002-h

Review

Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reduction

J Koning et al. Cancer Treat Rev. 1991 Mar.

. 1991 Mar;18(1):1-19.

doi: 10.1016/0305-7372(91)90002-h.

Authors

J Koning¹, P Palmer, C R Franks, D E Mulder, J L Speyer, M D Green, K Hellmann

Affiliation

¹ EuroCetus B.V., Amsterdam, The Netherlands.

PMID: 1933909
DOI: 10.1016/0305-7372(91)90002-h

No abstract available

PubMed Disclaimer

Similar articles

Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias.
Lemez P, Maresová J. Lemez P, et al. Neoplasma. 1996;43(6):417-9. Neoplasma. 1996. PMID: 8996568
Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits.
Herman EH, Ferrans VJ, Jordan W, Ardalan B. Herman EH, et al. Res Commun Chem Pathol Pharmacol. 1981 Jan;31(1):85-97. Res Commun Chem Pathol Pharmacol. 1981. PMID: 6789416
The cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity.
Kwok JC, Richardson DR. Kwok JC, et al. Redox Rep. 2000;5(6):317-24. doi: 10.1179/135100000101535898. Redox Rep. 2000. PMID: 11140743 Review.
[The role of cardioxane (ICRF-187) in the prevention of cardiotoxicity of anthracyclines in the combined drug therapy of extensive ovarian cancer].
Protasov DA, Zel'dovich DR, Kuz'mina LP, Manikhas GM. Protasov DA, et al. Vopr Onkol. 1998;44(6):718-21. Vopr Onkol. 1998. PMID: 10087973 Clinical Trial. Russian.
Dexrazoxane (ICRF-187).
Weiss G, Loyevsky M, Gordeuk VR. Weiss G, et al. Gen Pharmacol. 1999 Jan;32(1):155-8. doi: 10.1016/s0306-3623(98)00100-1. Gen Pharmacol. 1999. PMID: 9888268 Review.

See all similar articles

Cited by

Systemic therapy of advanced breast cancer.
Mouridsen HT. Mouridsen HT. Drugs. 1992;44 Suppl 4:17-28; discussion 66-9. doi: 10.2165/00003495-199200444-00003. Drugs. 1992. PMID: 1283847 Review.
Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients.
Elbl L, Hrstkova H, Tomaskova I, Blazek B, Michalek J. Elbl L, et al. Eur J Pediatr. 2005 Nov;164(11):678-84. doi: 10.1007/s00431-005-1732-x. Epub 2005 Jul 26. Eur J Pediatr. 2005. PMID: 16044276 Clinical Trial.
Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC).
Rosing H, ten Bokkel Huinink WW, van Gijn R, Rombouts RF, Bult A, Beijnen JH. Rosing H, et al. Eur J Drug Metab Pharmacokinet. 1999 Jan-Mar;24(1):69-77. doi: 10.1007/BF03190013. Eur J Drug Metab Pharmacokinet. 1999. PMID: 10412894 Clinical Trial.
Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.
Elbl L, Hrstkova H, Tomaskova I, Michalek J. Elbl L, et al. Support Care Cancer. 2006 Feb;14(2):128-36. doi: 10.1007/s00520-005-0858-8. Epub 2005 Jul 21. Support Care Cancer. 2006. PMID: 16034614 Clinical Trial.
New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer.
Kontoghiorghes GJ. Kontoghiorghes GJ. Int J Mol Sci. 2022 Nov 13;23(22):13990. doi: 10.3390/ijms232213990. Int J Mol Sci. 2022. PMID: 36430469 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science